Increased Levels of Soluble ST2 in Patients with Active Newly Diagnosed ANCA-Associated Vasculitis

Table 3

Ranges and medians of sST2 levels and IL-33 levels in AAV patients.

Group of patients (number of samples)	sST2 ng/mL		IL-33 (ng/mL)
	Median	Range	Median	Range
All AAV (165)	0.16	0–1.17	0	0–2.60
Active AAV (38)	0.19	0–1.17	0	0–0.29
Active newly diagnosed AAV (16)	0.39	0–1.17	0	0.00
Remission AAV (127)	0.17	0–0.76	0	0–2.60
Control group (62)	0.13	0.10–10.15	0	0.00